johnson and johnson
j

Johnson & Johnson’s $1.7 Billion Drug Success Signals Growth in Psychedelic Medicine Market

Johnson & Johnson’s Spravato, a nasal spray derived from ketamine, has reached blockbuster status with annual sales exceeding $1 billion. Approved in 2019 for...

Popular

Defence Secretary John Healey Resigns

UK Defence Secretary John Healey has unexpectedly resigned from...

New York City Launches Street Soccer Initiative to Increase Access to the Sport

New York City has launched a major street soccer...

Singaporean Households Can Claim S$500 CDC Vouchers From June 11

Starting 11 June, all Singaporean households can claim S$500...

New York Penn Station Rehabilitation Project Seeks Billions in Federal Funding

The rehabilitation of New York’s Penn Station is moving...
spot_imgspot_imgspot_img
spot_imgspot_imgspot_imgspot_img